Serum cholesterol distribution and coronary heart disease risk - Observations and predictions among middle-aged population in eastern Finland

被引:64
作者
Jousilahti, P
Vartiainen, E
Pekkanen, J
Tuomilehto, J
Sundvall, J
Puska, P
机构
[1] Natl Inst Publ Hlth, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland
[2] Natl Publ Hlth Inst, Environm Epidemiol Unit, Kuopio, Finland
[3] Natl Inst Publ Hlth, Dept Biochem, FIN-00300 Helsinki, Finland
关键词
cholesterol; coronary disease; mortality; prevention;
D O I
10.1161/01.CIR.97.11.1087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The purpose of the present study was to assess the implications of cholesterol distribution and its change on coronary heart disease (CHD) mortality and disease prevention at a population level. Methods and Results-In five independent risk factor surveys (1972, 1977, 1982, 1987, and 1992) in eastern Finland, serum cholesterol was measured in 27 721 randomly selected men and women aged 30 to 59 years. The association between cholesterol level and CHD risk and the prediction of the effect of different prevention strategies was estimated by use of logistic regression models. The entire cholesterol distribution of the population shifted markedly toward lower levels between 1972 and 1992. The proportion of subjects with a very high cholesterol level (greater than or equal to 8.0 mmol/L), also decreased markedly, fi-om 16% to 3%. The risk of CHD death among subjects with cholesterol greater than or equal to 8.0 mmol/L was approximate to 5-fold that of those individuals having cholesterol <5.0 mmol/L. Nevertheless, because CHD risk increases continuously as serum cholesterol increases, and because the number of people having only slightly or moderately increased serum cholesterol was large, most CHD deaths occurred among them. A 10% reduction in cholesterol levels in the entire population would subsequently reduce CHD mortality by 20%, as much as an effective treatment as a 25% decrease in serum cholesterol among all subjects with cholesterol >6.5 mmol/L, and four times more than similar treatment of all subjects with cholesterol greater than or equal to 8.0 mmol/L. Conclusions-The community-based population strategy in cardiovascular disease prevention was effective in decreasing cholesterol levels among the entire population, including the subjects with the highest cholesterol values. The balanced application of both high-risk and population strategies is needed for the effective prevention of CHD.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 34 条
  • [1] [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4
  • [2] Statins and coronary heart disease
    Fey, R
    Pearson, N
    [J]. LANCET, 1996, 347 (9012) : 1389 - 1390
  • [3] *INT STEER COMM, 1991, WORLD HLTH STAT Q, V44, P48
  • [4] Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
    Johannesson, M
    Jonsson, B
    Kjekshus, J
    Olsson, AG
    Pedersen, TR
    Wedel, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) : 332 - 336
  • [5] Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland
    Jousilahti, P
    Vartiainen, E
    Tuomilehto, J
    Puska, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (09) : 713 - +
  • [6] EFFECT OF RISK-FACTORS AND CHANGES IN RISK-FACTORS ON CORONARY MORTALITY IN 3 COHORTS OF MIDDLE-AGED PEOPLE IN EASTERN FINLAND
    JOUSILAHTI, P
    VARTIAINEN, E
    TUOMILEHTO, J
    PEKKANEN, J
    PUSKA, P
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (01) : 50 - 60
  • [7] SERUM CHOLESTEROL RESPONSE TO CHANGES IN DIET .4. PARTICULAR SATURATED FATTY ACIDS IN DIET
    KEYS, A
    ANDERSON, JT
    GRANDE, F
    [J]. METABOLISM, 1965, 14 (07): : 776 - &
  • [8] SYSTEMATIC UNDERESTIMATION OF ASSOCIATION BETWEEN SERUM-CHOLESTEROL CONCENTRATION AND ISCHEMIC-HEART-DISEASE IN OBSERVATIONAL STUDIES - DATA FROM THE BUPA STUDY
    LAW, MR
    WALD, NJ
    WU, T
    HACKSHAW, A
    BAILEY, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6925): : 363 - 366
  • [9] LOW MR, 1994, BMJ-BRIT MED J, V308, P373
  • [10] MCCORMICK J, 1988, LANCET, V2, P839